Actively Recruiting
Korean Post-marketing Surveillance for Somavert
Led by Pfizer · Updated on 2025-07-04
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to observe the safety and effectiveness of Somavert in people with acromegaly during routine medical care in Korea. It is an observational study conducted as part of regulatory requirements by the Ministry of Food and Drug Safety (MFDS) to monitor the drug after it has been marketed. Pfizer sponsors this study to gather real-world data on Somavert use. Participants in this study receive Somavert as they would in normal medical practice without any additional treatments or interventions from the study. The study follows patients from the start of treatment through about 52 weeks, tracking usage as it naturally occurs in healthcare settings. During the study, researchers will monitor participants for any adverse events from the beginning until 28 days after the last Somavert dose. They will also assess clinical improvement over approximately 52 weeks. The study involves routine medical assessments and data collection during regular visits, with no extra procedures required. Participants will be followed throughout this period to understand how Somavert performs in real-world use.
CONDITIONS
Brief Title
Korean Regulatory Post Marketing Surveillance for Somavert
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients prescribed Somavert according to local label and investigator's judgement
- Patients treated under routine medical practice settings in Korea
- Patients aged 18 years or older
- Patients with acromegaly
You will not qualify if you...
- Patients who have contraindications for Somavert
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to approximately 52 weeks
Participants who undergo routine care with Somavert are observed for safety and clinical improvement.
Visits as per routine medical practice
Trial Site Locations
Total: 1 location
1
Pfizer
Seoul, South Korea, 01037
Actively Recruiting
Research Team
P
Pfizer CT.gov Call Center
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here